Our commitments

Quality Policy

March 20, 2024

BIOPROJET Pharma is a European pharmaceutical laboratory that focuses its activity on clinical and pharmaceutical development, as well as the use and distribution of innovative pharmaceutical products that are pioneers in their therapeutic class (first in class).

To fulfil this mission, BIOPROJET Pharma relies on the skills and expertise of its Research Centre, BIOPROJET Biotech located in Rennes, and its operational departments of Clinical, Medical and Pharmaceutical Development, Regulatory Affairs, Pharmacovigilance, Marketing, Logistics, Quality Assurance, Finance and Human Resources, located in Paris.

Firm in the conviction that a quality policy is a key element in the fulfilment of our missions, we are committed to carrying out our activities as MA Holder and operator in full respect of applicable regulations in line with a continuous improvement process, undertaking to:

Work for the Proper Use of Drugs in compliance with the Code of Public Health;

Apply the standards of the various sets of Best Practices (Clinical, Manufacturing, Distribution, Pharmacovigilance, Promotional Information) and the Code of Public Health;

Listen and respond to the expectations of healthcare professionals, patient associations and patients themselves;

Respond to requests for scientific, medical, or pharmaceutical information from healthcare professionals is a non-proactive and non-promotional manner with no promotional interactions whatsoever.

Make the quality, efficacy and safety of our products a major responsibility for management and all staff;

Take on quality objectives and quality and performance indicators as criteria for company excellence and management;

Communicate our quality objectives to all staff and deploy them in all relevant company roles so that everyone is involved in the process;

Raise awareness and train all staff on the stakes and impact of their work on the quality and performance of BIOPROJET Pharma business activities.

With regard to information activities via solicitation or market research aimed at the promotion of medicines created by or on behalf of BIOPROJET Pharma, BIOPROJET Pharma undertakes to apply the principles of the Charter signed between the Economic Committee for Health Products and Pharmaceutical Companies, specifically by submitting our organisation to the certification procedure according to the associated standard under the control of the Haute Autorité de Santé [French Healthcare Authority]. Our Quality Objectives in terms of promotional information are as follows :

Fostering the proper use of drugs by delivering as complete and objective information as possible to healthcare professionals, in full respect of the charter and the certification standard for soliciting or market research information with a view to promoting drugs;

Guaranteeing the scientific, medical and economic quality of documents presented or delivered to healthcare professionals and those used by the company and its subcontractors to train and assess individuals carrying out promotional information activities;

Ensuring transparent, fair and quality communication on our products in the context of local regulations, ethical rules and best practices for maintenance of the certification;

Developing the scientific and medical skills of individuals responsible for promotional information through suitable integration and continuous training;

Overseeing the quality of our promotional information service providers in a process of continuous improvement;

Taking into account feedback from healthcare professionals to improve their satisfaction;

Raise awareness of promotional information activities across all of the company’s sectors.

Having formed a network of partnerships that is important in the context of subcontracting activities or service provision, we disseminate and apply the principles of our Quality Policy in the monitoring of these subcontracted activities.

Together, we undertake to assign the human, technical, financial and organizational resources necessary for the implementation of the Quality Policy, which forms part of our commitment as a player in the Healthcare System.

Jean-Stéphane JULIEN – CEO and Qualified Person | Philippe LEROY – Managing Director | Elise CHAUVEL – Quality & Compliance Manager

Ethics
& Transparency Commitment

Charter for information activities
via soliciting or market research aimed at the promotion of drugs

    • Bioprojet is committed to a certification process for its drug promotion information activities by Bureau Véritas. Our promotional activities in private clinics and hospitals have been subject to certification according to HAS standards from March 2017.

     

Corporate Social Responsibility

At Bioprojet, an independent and responsible laboratory, our vocation is guided by Research and Innovation. Our mission is to serve patients by developing and delivering innovative therapies that meet unmet medical needs.

Our commitments are structured around three fundamental pillars, which reflect our DNA and values :

Delivering innovative therapies to patients.

Building trust-based relationships with our employees.

Embedding environmental considerations into all our decisions.

These pillars form the foundation of our Corporate Social Responsibility (CSR) approach, underscoring our dedication to sustainable and ethical development.

Our Pillars of Commitment

1. Delivering Innovative Therapies to Patients

Bioprojet prioritizes the development and availability of “first-in-class” treatments that address unmet medical needs, a cornerstone of our mission. This commitment is activated especially in :

Prioritizing unmet medical needs : Driving the development of cutting-edge therapeutic solutions to address key public health challenges.

Improving access to healthcare : Facilitating access to our treatments.

Securing the supply of medicines : Ensuring the reliable and continuous availability of our products, adhering to the highest quality and safety standards.

This pillar embodies Bioprojet’s core belief in innovation and its unwavering commitment to serving patients with therapies that make a meaningful difference in their lives.

2. Building Trust-Based Relationships with Our Employees

At Bioprojet, we foster a culture of trust and care, rooted in our family-business values. This pillar reflects our commitment to :

Recruiting, developing, and retaining talent by providing opportunities for professional development, training, and long-term career fulfillment.

Ensuring quality of life at work, creating a supportive, inclusive and flexible environment for all employees.

Promoting transparency and responsible communication, ensuring clarity and trust in all interactions with employees, partners, and stakeholders.

This approach reflects Bioprojet’s commitment to goodwill and respect towards towards employees and partners throughout our all value chain.

3. Embedding Environmental Considerations into Our Decisions

Bioprojet is committed to being a responsible actor, aware of its impact on the world and society. This responsibility is demonstrated through :

Continuously optimizing our operations and adopting environmentally friendly decision and practices in order to reduce greenhouse gas emmissions.

Engaging employees and partners in sustainable development : Raising awareness and mobilizing collective action for environmental preservation.

Adopting sustainable practices : Integrating eco-design, resource optimization, and waste management throughout our value chain.

This pillar underscores Bioprojet’s determination to contribute to a more sustainable and equitable future by actively addressing its environmental footprint.

Implementation and Monitoring

To turn these commitments into action, Bioprojet has established :

Continuous dialogue with stakeholders, including patients, employees, partners, and civil society, to align our efforts with their expectations.

Conclusion

At Bioprojet, we integrate Corporate Social Responsibility at the heart of our strategy, confident that our actions today will positively shape the health and well-being of future generations. Guided by our values of innovation, trust, and responsibility, we aim to be a laboratory that not only serves patients but also contributes meaningfully to a sustainable and equitable society.

This commitment extends beyond our own operations, as it also involves all our suppliers. We require them to comply with our Supplier CSR Charter, ensuring that every stakeholder in our value chain shares our vision and commits to meeting the strict ethical, social, and environmental standards we have established. In doing so, we work together for a more responsible future, with collaboration and transparency at the heart of our continuous improvement process.